PD Dr. Markus Eckstein

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Institute of Pathology

Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening (2018) Rinaldetti S, Rempel E, Worst TS, Eckstein M, Steidler A, Weiss CA, Bolenz C, et al. Journal article High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma (2018) Breyer J, Wirtz RM, Erben P, Worst TS, Stoehr R, Eckstein M, Bertz S, et al. Journal article Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer (2018) Kriegmair MC, Wirtz RM, Worst TS, Breyer J, Ritter M, Keck B, Boehmer C, et al. Journal article A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy (2018) Eckstein M, Wirtz RM, Pfannstil C, Wach S, Stoehr R, Breyer J, Erlmeier F, et al. Journal article High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients (2018) Breyer J, Wirtz RM, Otto W, Erben P, Worst TS, Stoehr R, Eckstein M, et al. Journal article Urothelial Bladder Cancer: An Update on Molecular Pathology with Clinical Implications (2017) Bertz S, Eckstein M, Stoehr R, Weyerer V, Hartmann A Journal article Primary mixed adeno-neuroendocrine carcinoma (MANEC) of the urinary bladder: a rare entity (2017) Eckstein M, Rasper B, Busche J, Stachetzki U, Wistuba DE, Agaimy A, Hartmann A, Bertz S Journal article ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ (2017) Breyer J, Otto W, Wirtz RM, Wullich B, Keck B, Erben P, Kriegmair MC, et al. Journal article High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer (2017) Sikic D, Breyer J, Hartmann A, Burger M, Erben P, Denzinger S, Eckstein M, et al. Journal article FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes (2017) Rinaldetti S, Wirtz RM, Worst TS, Eckstein M, Weiss CA, Breyer J, Otto W, et al. Journal article